Tandem Diabetes Care Inc. held a virtual Annual Meeting of Stockholders on May 21, 2025. At the meeting, stockholders elected eight directors. A proposal to approve the compensation of named executive officers was approved. The frequency of future stockholder advisory votes on executive compensation was set to every one year. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tandem Diabetes Care Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001438133-25-000112), on May 23, 2025, and is solely responsible for the information contained therein.